CHELMSFORD, Mass.--(BUSINESS WIRE)--June 13, 2006--ZOLL Medical Corporation (NASDAQ: ZOLL - News), a manufacturer of resuscitation devices and software solutions, today commented on the publication of two studies--known as the "ASPIRE Trial" and the "Richmond Study"--that relate to the AutoPulse® Non-invasive Cardiac Support Pump. The results of these two studies were first presented during the Resuscitation Science Symposium (ReSS) at the November 2005 meeting of the American Heart Association in Dallas. ReSS holds formal discussions and forums about advances in treating cardiac arrest.
